Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
US5888510A · kind A · utility
200Cited by
3References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 1997 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Apr 7, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for inhibiting synovial cell growth and treating chronic rheumatoid arthritis are provided. The methods comprise administering a pharmaceutical composition comprising an interleukin-6 antagonist, such as an anti-IL-6 receptor antibody, and a physiologically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.